TrialCancer immunology, immunotherapy : CII2026

Rosuvastatin enhances the efficacy of venetoclax-azacitidine in older acute myeloid leukemia patients via reducing T-cell exhaustion.

Yuanmei Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.